Introduction
The molecular mechanisms responsible for the development of the idiopathic cases of Alzheimer disease (AD) are unknown. Growing evidence indicates that cerebral elevation and accumulation of Aβ peptide mediate many aspects of AD pathogenesis. It has been difficult to determine which of the forms of Aβ induces neuropathological changes that characterize the disease. Oligomers have been found in mouse models of AD (Billings et al., 2005; Oddo et al., 2006) and have been detected in CSF (Kuo et al., 1996; Kayed et al., 2003 ) and brain tissue (Gong et al., 2003; Kayed et al., 2003; Lacor et al., 2004) of AD patients, where the soluble Aβ species appear to correlate with disease progression (Lue et al., 1999; McLean et al., 1999; Naslund et al., 2000) . Several mechanisms have been proposed to understand the Aβ-mediated neurodegeneration. AD has been related to a general dyshomeostasis of [Ca 2+ ] i . This hypothesis is substantiated by reports on dysregulation of [Ca 2+ ] i promoted by Aβ (LaFerla, 2002) . Whether Aβ directly alters lipid bilayer by forming pores or acts through proteinaceous receptor, for example α7-nACh or NMDA receptor is a matter of intense debate (Wang et al., 2000 , Arispe et al., 2007 , De Felice et al., 2007 . Growing evidences point to a major role for changes in [Ca 2+ ] i and Aβ-induced neuronal cell damage. First, Aβ oligomers provoke neurotoxicity by mechanisms that involve a channel independent disruption of the integrity of both plasma and intracellular membranes with elevation in [Ca 2+ ] i (Demuro et al., 2005) . Later, it has been reported that dynamin-1 degradation is the result of calpain activation induced by the Ca 2+ influx mediated by NMDA receptors in hippocampal neurons (Kelly and Ferreira, 2006) . Most recently, some studies have shown that Aβ oligomers bind to or in close proximity to NMDA receptor, triggering neuronal damage through NMDA receptor dependent Ca 2+ 5 flux or implicating excitatory receptor activity in oligomer formation and accumulation at synapses (De Felice et al., 2007; Deshpande et al., 2009 ).
On the other hand, accumulated evidence indicates that physiological concentrations of Aβ peptides can regulate the release of glutamate by acting on glutamatergic terminals (Kabogo et al., 2008) . Consistent with that idea, soluble Aβ perturbs synaptic plasticity by altering glutamate recycling at the synapse and promoting synapse depression (Li et al., 2009 -dependent glutamate excitotoxicity (Mattson et al., 1992) . 
Materials and Methods
Drugs and culture medium. Neurobasal medium, B27 supplement, foetal bovine serum, horse serum and other culture reagents were from Gibco (Invitrogen, Barcelona, Spain).
Receptor antagonists MK801, DAP5 (AP5), and memantine were all obtained from Tocris (Cookson, Bristol, UK). CNQX and other chemicals were from Sigma (St Louis, MO, USA). The general caspase inhibitor ZVAD and the caspase-3 specific inhibitor DEVD were purchased in Peptides International (Louisville, KY, USA). DPQ, the PARP-1 inbibitor, was obtained from Calbiochem (La Jolla, CA, USA).
Preparation of Aβ oligomers. Aβ1-42 oligomers were prepared as reported previously (Klein, 2002) . Briefly, Aβ1-42 (ABX, Radeberg, Germany) was initially dissolved to 1 mM in hexafluoroisopropanol (Sigma; St Louis, MO, USA) and separated into aliquots in sterile microcentrifuge tubes. Hexafluoroisopropanol was totally removed under vacuum in a speed vac system and the peptide film was stored dessicated at -80 ºC. For the aggregation protocol, the peptide was first resuspended in dry DMSO (Sigma; St Louis, MO, USA) to a concentration of 5 mM and Hams F-12 (PromoCell, Labclinics, Barcelona, Spain) was added to bring the peptide to a final concentration of 100 μM and incubated at 4 ºC for 24h. The preparation was then centrifuged at 14,000 x g for 10 min at 4 ºC to remove insoluble aggregates and the supernatants containing soluble Aβ1-42 was transferred to clean tubes and stored at 4 ºC.
Cortical cell culture. Primary neuron cultures were obtained from the cortical lobes of E18 Sprague-Dawley rat embryos according to previously described procedures (Gottlieb et al., 2006) . Cells were resuspended in B27 Neurobasal medium plus 10% FBS (Sigma; St Louis, MO, USA) and then seeded onto poly-l-ornithine-coated glass coverslips at 1 x 10 5 cells per coverslip (12 mm in diameter) and 48-well plates at 1.5 x 10 5 per well. One day later, the medium was replaced by serum-free-, B27-7 supplemented Neurobasal medium. The cultures were essentially free of astrocytes and microglia; they were maintained at 37 ºC and 5% CO 2 . Cultures were used 8-10 days after plating. (Grynkiewicz et al., 1985) . Neurons were loaded with fura-2 AM (5 μM; software.
Measurement of mitochondrial Ca

2+
. Rhod-2 AM was used to measure mitochondrial Ca 2+ according to the previous procedure with modifications (Hajnóczky et al. 1995) .
Rhod2-AM has a net positive charge, which facilitates its sequestration into mitochondria due to membrane potential-driven uptake. Cell were loaded with 2 μM rhod2-AM for 6 hours. The residual cytosolic fraction of the dye was eliminated when the cells were kept in culture for an additional 18h after loading, whereas the mitochondrial dye fluorescence was maintained. Fluorescence images of rhod-2 were acquired using 550 nm excitation and 590 nm emission. The fluorescence of rhod-2 was not calibrated in terms of [Ca 2+ ]mit since it is not a ratiometric dye. Hippocampus-entorhinal cultures were exposed to Aβ oligomers at 100 nM for 4 days.
Measurement of
Antagonists were added to cultures 30 min before the Aβ. Cell death in organotypic cultures was evaluated by cellular uptake of propidium iodide (PI). Slices were stained by adding 10 μM PI into the culture for 2 h at 37° C and washed with PBS by two times for 10 min. Slices were fixed with 4% PFA in PBS for 40 min at room temperature (Pozzo-Miller et al., 1994) . Afterwards, the slices were excited with 510-560 nm light and the emitted fluorescence acquired at 610 nm using a rhodamine filter on an inverted fluorescence microscope (Cell Observer Z1, Zeiss). PI fluorescence images were captured with a Plan NeoFluar 2.5 x objective (Zeiss), using an EM CCD camera (Hamamatsu, C9100-13), controlled by Axio Vision program (Zeiss). Images were analyzed with the ImageJ analysis program (NIH, MD, USA) and neuronal cell death was expressed as the percentage of the mean gray value of each treatment vs. control.
Measurement of intracellular reactive oxygen species. Neurons were exposed to Aβ oligomer alone or with GluR antagonists as described. Cells were loaded with CM-H2DCFDA at 30 μM to assay the ROS levels. Calcein-AM (1 μM; Molecular Probes, Invitrogen, Barcelona, Spain) was used to quantify the number of cells within the reading field. Fluorescence was measured using a Synergy-HT fluorimeter (Bio-Tek
Instruments Incl, Beverly, MA, USA) and excitation and emission wavelengths for CM-H2DCFDA and calcein were as suggested by the supplier. All experiments (n≥3) were performed at least in quadruplicate and plotted as means ± SEM.
Analysis of mitochondrial membrane potential. Neurons were exposed to Aβ oligomers alone or in presence of different drugs and the changes in mitochondrial membrane potential were monitored by reduction of JC-1 (Molecular Probes, Invitrogen, Barcelona, Spain), according to the manufacturer protocol. Briefly, after drug treatment, cells were loaded with 3 μM JC-1 for 15 min at 37 ºC and were washed with HBSS without phenol red by two times to eliminate the excess of dye. In the cytosol the monomeric form of this dye fluoresces green (excitation at 485 nm, emission at 527 nm), whereas within the mitochondrial matrix highly concentrated JC-1 forms aggregates that fluoresce red (excitation at 485 nm, emission at 590 nm). Both JC-1 monomers and aggregates were detectable using a Synergy-HT fluorimeter (Biotek Instruments) and the changes in mitochondrial potential were calculated as the red/green ratio in each condition. All experiments (n ≥ 3) were performed at least in triplicate and plotted as mean ± SEM. ), Aβ oligomers (1 μM) induced an inward current in the majority of neurons examined (816 ± 101 pA; n=30). AP5 (100 μM), a competitive NMDA antagonist, reduced the peak of the currents (n=7). Silencing neural activity with TTX (1 μM) or using a calcium-free extracellular bath solution did not attenuate the response to Aβ oligomers suggesting a direct interaction of the peptide with NMDA receptors (n= 11 and 13 respectively; Fig 1A) . Fig 1B) .
Together these results provide evidence indicating that Aβ oligomers activate NMDA receptors in cortical cultured neurons.
Previous results have shown that Aβ(1-42) but not Aβ(1-40) closely interacts with synaptic AMPA receptors (Parameshwaran et al., 2007) . Because of that, we next examined whether Aβ oligomers also activate AMPA receptors in cultured neurons. In the presence of Mg 2+ and no glycine, Aβ (1 μM) alone elicited a small current (43 ± 14 pA, n= 6) and co-applied with cyclothiazide (CTZ), an inhibitor of AMPA receptor desensitization, activated a sustained current (n=18; Fig 2A) that was blocked by the AMPA/kainate antagonist CNQX (n= 6; Fig 2A) . We then measured the effects of antagonists of NMDA or AMPA receptor on [Ca 2+ ] i in neurons exposed to Aβ plus CTZ (5 μM and 100 μM, respectively; Fig 2B) . In these experimental conditions, Aβ oligomers increased the [Ca 2+ ] i in 308 ± 44.7 nM (100 % of Ca 2+ increase, control value, n=23) a level that was substantially reduced by CNQX 30 μM (50 ± 4 % of control, n=17) and by AP5 100 μM (45 ± 2 % of control, n=17; Fig. 2B ). Co-incubation with CNQX and AP5 further reduced [Ca 2+ ] i to 14 ± 2 % of control (n=18; Fig. 2B (Fig 3A) . In turn, Aβ toxicity (5 μM; 15.2 ±1.8 % cell death vs. nontreated cells) was greatly attenuated by NMDA receptor antagonists AP5 100 μM, MK801 50 μM and memantine 50 μM and by AMPA/kainate receptor antagonist CNQX 30 μM (Fig. 3B) .
Previous reports have shown that oligomeric Aβ peptides induce mitochondrial dependent-apoptotic cell death in cultured neurons (Sanz-Blasco et al., 2008). Damage
to mitochondria can result in both caspase-dependent and -independent cell death. To characterize whether these two types of apoptosis are involved in GluR-mediated Aβ toxicity, we used the pan-caspase inhibitor ZVAD-F, a caspase-3 inhibitor Ac-DEVD-F and the nuclear enzyme poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor DPQ. We observed that ZVAD-F (50 μM), DEVD (100 μM) and DPQ (30 μM) reduced Aβ-induced cell death (Fig. 3C) . Aβ toxicity decreased further by blocking simultaneously caspase-3 and PARP-1 with DEVD + DPQ (Fig. 3C) . These results indicate that Aβ oligomers induce caspase-3-and PARP-1-dependent neuronal death via activation of NMDA and AMPA receptors.
Aβ oligomers induce mitochondrial damage by activating glutamate receptors
To characterize further the signalling cascades triggered by Aβ oligomers, we next studied mitochondrial Ca 2+ uptake in neurons with rhod-2 AM, a cationic indicator which loads selectively into respiring mitochondria. To assess that feature, we used FCCP 25 μM, a protonophore that collapses the mitochondria membrane potential and releases Ca 2+ from mitochondria. As expected, FCCP induced a rapid and transitory reduction of rhod-2 fluorescence (Fig 4A) . ] mit levels with respect to the control assay (incubation buffer). Ca 2+ rise was reduced by NMDA antagonist MK801, AP5 and memantine, whereas CNQX was ineffective (Fig 4B and C) . These results indicate that Aβ induces mitochondrial Ca 2+ overload and that this effect can be prevented by NMDA receptors antagonists.
Aβ induces mitochondrial dysfunction by an NMDA receptor-dependent mechanism in hippocampal neurons (De Felice et al., 2007) . Consistently, we observed that NMDA antagonists reduce Aβ-generated oxidative stress (Fig. 4D ) and mitochondrial depolarization (Fig. 4E ) in cortical neurons. Incubation of neurons with Aβ (5 µM; 2 hours) increased ROS levels to 124 ± 7.8 % and reduced the mitochondrial potential to 75 ± 3% with respect to control (100%, non-treated cells). Both parameters were partially restored by NMDA receptor antagonists AP5 (102 ± 11 % and 90 ± 2 %, respectively) and MK801 (104 ± 3.4 % and 85 ± 3 %, respectively) and by AMPA receptor antagonist CNQX (106 ± 6.3 % and 86 ± 3 %, respectively; Fig. 4D and E).
Taken together, these results demonstrate that both NMDA and AMPA receptors mediate Aβ-induced mitochondrial dysfunction.
Blockade of NMDA and AMPA receptors protect from Aβ-induced toxicity in entorhinal cortex-hippocampus organotypic slices
We next examined if Aβ oligomers induce Ca 2+ and cell death in a more integral preparation. To that end, we used organotypic cultures from entorhinal cortex and hippocampus, two regions that are profoundly affected early in Alzheimer´s disease and cause cardinal symptoms of short-term memory loss (De Lacoste and White, 1993) .
Slices for organotypic cultures were prepared as to preserve major connections between entorhinal cortex and hippocampus (Kluge et al., 1998) . Thus, neurofilament immunofluorescence with antibodies to NFL revealed axons entering the hippocampus from the entorhinal cortex and layer preservation of these structures (Fig. 5A , B and C).
In addition, antibodies to choline acetyltransferase show cholinergic fibers and terminals in entorhinal cortex (Fig. 5 D) .
To monitor the effects of Aβ in these cultures, we measured Ca 2+ levels after application of Aβ to neurons from CA1 in organotypic slices. We found that oligomeric Aβ (20 μM) increased [Ca 2+ ] i in those cells, and that this response was greatly reduced by MK801 (50 μM, n=9) and CNQX (30 µM, n=43) treatment (Fig 5E) . Aβ-induced [Ca 2+ ] i decreased further by blocking simultaneously NMDA and AMPA receptors with MK801+CNQX (n=50; Fig 5E) . In turn, Ca 2+ responses elicited by kainate (1 mM) served as a positive control to evaluate the integrity of the culture (Fig. 5E) .
Finally, to test Aβ toxicity we chronically incubated cultures with low concentrations of Aβ oligomers (100 nM) for 4 days, and used PI fluorescence to measure cell death. PI uptake in slices exposed to Aβ showed 4.1 ± 1.0 and 3.8 ± 0.9 fold over the control slices (n=7) in hippocampus and entorhinal cortex respectively ( Fig. 5F-G) . Instead, co-incubation of GluR antagonists MK801 (10 μM) or CNQX (30 μM) with Aβ oligomers reduced PI uptake to 0.9 ± 0.2 and 1.3 ± 0.4 fold in hippocampus and to 1.2 ± 0.4 and 0.73 ± .01 fold in entorhinal cortex as compared to control slices treated with MK801 or CNQX alone (Fig 5F-G) .
Overall, these results indicate that Aβ induces cytosolic Ca 2+ overload and cell death in organotypic cultures, and that antagonists of NMDA and AMPA receptors prevent both effects.
Discussion
The results reported here show that Aβ oligomers dysregulate intracellular Ca 2+ homeostasis through activation of both NMDA and AMPA receptors in neurons in vitro and in enthorinal cortex-hippocampus organotypic cultures. Ca 2+ influx by GluRs produces mitochondrial dysfunction as indicated by mitochondrial Ca 2+ overload, oxidative stress and mitochondrial membrane depolarization, which ultimately leads to apoptotic cell death. In turn, NMDA and AMPA receptor antagonists protect neurons against Aβ-mediated toxicity by attenuating Ca 2+ influx and associated signaling cascades.
Several mechanisms may account for the Ca 2+ mobilizing actions of Aβ oligomers in the experimental paradigm used in the current study. These include a direct interaction with membrane structure; insertion into the membrane to form a cationconducting pore; activation of cell surface receptors coupled to Ca 2+ influx; and oxidative stress leading to dysregulation of mitochondrial homeostasis (Wang et al., 2000 , Arispe et al., 2007 , De Felice et al., 2007 , Sanz-Blasco et al., 2008 ] i is greatly reduced by MK801, AP5 and memantine, and also by CNQX.
Consistent with the findings reported here, it has been suggested that Aβ interacts directly with NMDA and AMPA receptors and modulates channel properties.
Thus, treatment of Aβ oligomers potentiate NMDA-evoked firing and induce a rapid and transient increase in intracellular Ca 2+ levels that is blocked by memantine in mature hippocampal neurons (Szegedi et al., 2005; De Felice et al., 2007) . In turn, Aβ oligomers have also been shown to induce Ca 2+ influx, calpain activation and dynamin-1 degradation mediated by NMDA receptor activation (Kelly and Ferreira, 2006) . In contrast, the reported effects of Aβ on AMPA receptors are apparently contradictory depending on the aggregation state of the peptide itself or the cell type studied. Thus, the fibrillar form of Aβ can robustly activate Ca 2+ permeable AMPA receptor in neuronal cell lines (Blanchard et al., 2004) while it attenuates AMPA-evoked neuronal firing in CA1 neurons (Szegedi et al., 2005) and currents mediated by recombinant AMPA receptors expressed in Xenopus oocytes (Tozaki et al., 2002 Atlante et al., 2001) . Consistent with that, we also observed these two deleterious features after treatment with Aβ oligomers, and that both are prevented by NMDA and AMPA receptor antagonists.
Increased levels of free radicals and Ca 2+ overload in mitochondria lead to the release into the cytoplasm of proapoptotic factors (Nicholls and Budd, 2000) .
Cytochrome c and the apoptosis-inducing factor are released from mitochondria to the cytosol and the nucleus, in which they induce activation of caspase-3 and PARP-1. In the current study, the fact that caspase-3 and PARP1 inhibition rescue neurons from
Aβ oligomeric toxicity strongly suggests that Aβ kills neurons by apoptosis involving both caspase-dependent and independent pathways.
Finally, we observed that Aβ oligomers induce neurotoxicity in cortical cell culture, and in entorhinal cortex and hippocampal organotypic slices. That toxicity was attenuated by NMDA and AMPA receptor antagonists in the two preparations assayed.
Of all vulnerable regions, pyramidal neurons of the neocortex, entorhinal cortex and hippocampus are affected early in the disease process (Butterfield and Pocernich, 2003; Cacabelos et al.1999 , Francis, 2003 . It also has been proposed that a sustained increase in extracellular glutamate levels and activation of the NMDA receptor is associated with the cognitive deficits and loss of neurons observed in AD brains (Mattson and Chan, 2003; Hynd et al., 2004 
